ZDHHC9媒介のSTAT1パルミトイレーション-リン酸化変換をターゲットにすることで,胃がんの進行を抑制します
Xiao Bai1, Yun-Ran Guo2, Wan-Chuan Zhang3
1Department of Surgical Oncology, The Fourth Affiliated Hospital of China Medical University, Shenyang, 110032, China.
Journal of gastroenterology
|February 19, 2026
まとめ
ZDHHC9は,STAT1をパルミトイロ化することによって胃がん (GC) を促進し,そのリン酸化に影響を与え,腫瘍の成長を促します. このプロセスを阻害することは,GC治療の潜在的な治療戦略を提供します.
科学分野:
- 腫瘍学 腫瘍学
- 分子生物学は分子生物学である.
- バイオケミストリー バイオケミストリー
背景:
- パルミトイル移転酵素 (ZDHHCs) とタンパク質のパルミトイル化が様々ながんに関与しています.
- 胃がん (GC) でのZDHHCsとパルミトイロ化の特定の役割は,ほとんど不明のままです.
研究 の 目的:
- 胃がんにおけるZDHHCsとタンパク質パルミトイレーションの役割を調査する.
- GC進行におけるZDHHC9とSTAT1を関与させる根本的な分子メカニズムを解明する.
主な方法:
- アシル-バイオチニル交換アッセイ,共免疫プレシピテーション,免疫ヒスト化学,ウェスタンブロット,免疫光,およびコンフォカル画像を用いた.
- ZDHHC9遺伝子の静止とパルミトイレーション阻害剤 (2-ブロモパルミテート) を使用した.
主要な成果:
- GCにおける広範なタンパク質パルミトイロ化が特定された;2-ブロモパルミタートはGCの進行を抑制した.
- 異常なZDHHC9過剰発現が発見され,GCの予後が悪かった.ZDHHC9を静止するとGCの成長が抑制され,アポトーシスが誘発された.
- 実証されたZDHHC9は,JAK1-STAT1経路経由でCys577とTyr701のリン酸化でSTAT1S-パルミトイロ化を媒介し,GCの進行を促します.
結論:
- ZDHHC9は,STAT1のS-パルミトイライレーションとリン酸化を調節することにより,GCの進行を促進します.
- ZDHHC9-STAT1軸は,胃がん治療の潜在的な治療標的を代表しています.
関連する概念動画
Inhibition of Cdk Activity
4.8K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.8K
Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
The JAK-STAT Signaling Pathway
10.2K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
10.2K
Gastritis II: Pathophysiology
52
The pathophysiology of gastritis begins with the colonization of the stomach lining by Helicobacter pylori (H. pylori). This bacterium spreads mainly via the oral-oral route through saliva or shared utensils, and can also be transmitted in overcrowded or unhygienic environments through contaminated water, despite its brief survival outside the body.ColonizationOnce ingested, H. pylori enters the stomach and begins colonization by navigating through the mucus layer lining the stomach wall. It...
52


